WebDrug interaction information. Severe interactions are highlighted with a red marker. Find out more about BNF interactions information. List of interactions for . 190 interactions . Acebutolol. ... Bisoprolol. Both Labetalol and Bisoprolol … Web136 interactions Abrocitinib Abrocitinib might increase the exposure to Edoxaban. Manufacturer advises caution. Severity: Moderate Evidence: Theoretical Acalabrutinib Edoxaban causes bleeding, as can Acalabrutinib ; concurrent use might increase the risk of developing this effect. Manufacturer advises use with caution or avoid. Severity: Severe
Bisoprolol: medicine to treat high blood pressure (hypertension)
WebClozapine. Clozapine can cause constipation, as can Solifenacin ; concurrent use might increase the risk of developing intestinal obstruction. Manufacturer advises caution. Severity: Severe. Evidence: Theoretical. Both Solifenacin and … WebMar 6, 2024 · Drug-Drug Interactions Last Updated: March 6, 2024 Ritonavir, a strong cytochrome P450 (CYP) 3A4 inhibitor and a P-glycoprotein inhibitor, is coadministered with nirmatrelvir to increase the … birch and lane.com
Atorvastatin Interactions BNF NICE
WebSee the list of drugs that interact with Rifampicin. Includes information on severity of interaction and the level of evidence for it. ... Find out more about BNF interactions information. List of interactions for Rifampicin. 319 interactions . ... Bisoprolol. Rifampicin slightly decreases the exposure to Bisoprolol. Manufacturer makes no ... WebBisoprolol Both Furosemide and Bisoprolol can increase the risk of hypotension. Bortezomib Both Furosemide and Bortezomib can increase the risk of hypotension. Bosutinib Furosemide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de pointes) when given with Bosutinib. Manufacturer makes no recommendation. WebBeclometasone with formoterol and glycopyrronium (Trimbow 172/5/9®) for maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year (August 2024) Funding decision: birch and ivory handbags